MyJournals Home  

RSS FeedsTargeting the vasopressin type-2 receptor for renal cell carcinoma therapy (Oncogene)

 
 

16 october 2019 08:00:09

 
Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy (Oncogene)
 




 
199 viewsCategory: Oncology
 
Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells (Oncogene)
Functional deficiency of DNA repair gene EXO5 results in androgen-induced genomic instability and prostate tumorigenesis (Oncogene)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten